biblio
“Synthesis and antimicrobial evaluation of novel 2'-aryl-4-aryl-2,4'-Bisthiazole and 2'-aryl-4-Pyridyl-2,4'-bisthiazole derivatives as potential antibacterial agents”, Polycyclic Aromatic Compound , vol. 44, no. 2, pp. 773-787, 2024.
, “Synthesis and antimycobacterial screening of a novel series of alpha-amino acids containing thiazole linker”, ARKIVOC, 2022.
, “Synthesis of new thiazole and pyrazole clubbed 1,2,3-triazol derivatives as potential antimycobacterial and antibacterial agents”, Polycyclic Aromatic Compounds, vol. 42, no. 6, pp. 3216-3237, 2022.
, “Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents”, Bioorganic Chemistry, vol. 115, p. 105192, 2021.
, “Synthesis and antimycobacterial screening of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-3-yl)quinoline derivatives”, Journal of Heterocyclic Chemistry, vol. 57, no. 11, pp. 3918-3929, 2020.
, “Synthesis and antimycobacterial evaluation of new 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives”, Medicinal Chemistry Research, vol. 28, no. 6, pp. 805-819, 2019.
, “Synthesis and biological evaluation of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)phenyl)-2-phenylthiazole derivatives”, Journal of Heterocyclic Chemistry, 2019.
, “Synthesis of new 1,3,4-oxadiazole and benzothiazolylthioether derivatives of 4-arylmethylidene-3-substituted-isoxazol-5(4H)-one as potential antimycobacterial agents”, Medicinal Chemistry Research, vol. 28, no. 11, pp. 1873-1884, 2019.
, “Thiazolyl-pyrazole derivatives as potential antimycobacterial agents”, Bioorganic & Medicinal Chemistry Letters, vol. 29, no. 10, pp. 1199-1202, 2019.
, “Synthesis and biological evaluation of new 2-aryl-4-((4-aryl-1H-1,2,3-triazol-1-yl)methyl)thiazole derivatives”, Research on Chemical Intermediates, vol. 44, no. 2, pp. 1247-1260, 2018.
, “Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives”, European Journal of Medicinal Chemistry, vol. 132, pp. 333-340, 2017.
, “Synthesis, antimycobacterial screening and molecular docking studies of 4-aryl-4′-methyl-2′-aryl-2,5′-bisthiazole derivatives”, Medicinal Chemistry Research, 2017.
,